Cardiovascular Research - Matrix and Inflammation in Atherosclerosis
21 – 30 of 43
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin
(
- Contribution to journal › Article
-
Mark
Inhibitory effect of UDP-glucose on cAMP generation and insulin secretion
(
- Contribution to journal › Article
-
Mark
The proteoglycan mimecan is associated with carotid plaque vulnerability and increased risk of future cardiovascular death
(
- Contribution to journal › Article
-
Mark
CD163+ macrophages are associated with a vulnerable plaque phenotype in human carotid plaques
(
- Contribution to journal › Article
-
Mark
Low Levels of CD4+CD28null T Cells at Baseline Are Associated With First-Time Coronary Events in a Prospective Population-Based Case-Control Cohort
(
- Contribution to journal › Article
-
Mark
Lipoprotein ability to exchange and remove lipids from model membranes as a function of fatty acid saturation and presence of cholesterol
(
- Contribution to journal › Article
-
Mark
Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events
(
- Contribution to journal › Article
-
Mark
Orphan G-protein coupled receptor 183 (GPR183) potentiates insulin secretion and prevents glucotoxicity-induced β-cell dysfunction
(
- Contribution to journal › Article
- 2019
-
Mark
A biomarker of collagen type I degradation is associated with cardiovascular events and mortality in patients with atherosclerosis
(
- Contribution to journal › Article
-
Mark
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease
(
- Contribution to journal › Article